PATENT CLAIM ANALYSIS

Application Number: 15873425
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "302000"]

Abstract:
Methods of treating tinnitus with gaboxadol or a pharmaceutically acceptable salt thereof are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of tinnitus. Methods of treating acute sensorineural hearing loss or Meniere's disease with gaboxadol or a pharmaceutically acceptable salt thereof are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of acute sensorineural hearing loss or Meniere's disease.

Claim (Index 15):
A method of treating acute sensorineural hearing loss comprising administering to a patient in need thereof gaboxadol or a pharmaceutically acceptable salt thereof wherein the method provides an in vivo plasma profile comprising a C max  less than about 400 ng/ml and wherein the method provides improvement in the patient for more than 6 hours after administration of the gaboxadol or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 2.35294
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15191068', '15185650', '15634250', '14834027', '15680417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7574837197493727
- 35 USC 102 Novelty (BERT): 0.5200121992907533
- Combined Prediction Score: 0.7337365677035108
- Mean Citation Score: 270.46661000000006
- Max Citation Score: 305.65613
- Similarity Product: 195.65191055754545

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test